Searchable abstracts of presentations at key conferences in endocrinology

ea0014p574 | (1) | ECE2007

Fractionated stereotactic conformal radiotherapy for skull base benign tumours: an endocrinological follow-up

Minniti Giuseppe , Traish Daphne , Ashley Sue , Gonsalves Adam , Brada Michael

Background: Stereotactic radiotherapy techniques have been recently employed in the control of skull base tumours, such as pituitary edenomas, craniopharyngiomas and meningiomas.Purpose: To assess the long-term endocrinological effect of fractionated stereotactic conformal radiotherapy (SCRT) in patients with residual and recurrent sellar and parasellar tumours treated at Royal Marsden Hospital.Patients and methods: 245 patients (m...

ea0014p581 | (1) | ECE2007

Effects of successful transsphenoidal surgery on cardiovascular function in elderly acromegalics

Minniti Giuseppe , Moroni Carlo , Esposito Vincenzo , Cassone Rosario , Cantore Gianpaolo , Jaffrain-Rea Marie Lise

Background: Transsphenoidal surgery (TSS) is able to determine the biochemical remission of acromegaly in 45%–80% of the patients, thereby inducing an improvement of cardiovascular function and glucose metabolism. Only 3–5% of acromegalics are diagnosed over 65-years-old, so few data are available about post-operative cardiovascular and metabolic changes in this group.Patients and Methods: Fifteen acromegalic patients ≥65 years-old who un...

ea0081rc4.1 | Rapid Communications 4: Pituitary and Neuroendocrinology 1 | ECE2022

Immunotherapy in a non-functioning metastatic pituitary neuroendocrine tumor. An encouraging case report

Feola Tiziana , Gianno Francesca , Verrico Monica , Giangaspero Felice , Tomao Silverio , Colonnese Claudio , Esposito Vincenzo , Isidori Andrea , Minniti Giuseppe , Jaffrain-Rea Marie-Lise

Introduction: Metastatic pituitary neuroendocrine tumors (PitNETs) or pituitary carcinomas are rare and challenging conditions. We present a recent and encouraging observation of a temozolomide (TMZ)-resistant clinically non-functioning metastatic PitNET showing a remarkable response to the anti-PDL1 drug Pembrolizumab.Case presentation: A 57-years-old man had transsphenoidal surgery in November 2012 for a large non-functioning intra/suprasellar mass rev...

ea0090p420 | Pituitary and Neuroendocrinology | ECE2023

Italian guidelines for the management of prolactinomas

Cozzi Renato , Simona Auriemma Renata , Pasquale De Menis Ernesto , Esposito Felice , Ferrante Emanuele , Iati Giuseppe , Mazzatenta Diego , Poggi Maurizio , Ruda Roberta , Tortora Fabio , Cruciani Fabio , Mitrova Zuzana , Saulle Rosella , Vecchi Simona , Basile Michele , Cappabianca Paolo , Paoletta Agostino , Papini Enrico , Persichetti Agnese , Samperi Irene , Scoppola Alessandro , Bozzao Alessandro , Caputo Marco , Doglietto Francesco , Ferrau Francesco , Lania Andrea , Laureti Stefano , Lello Stefano , Locatelli Davide , Maffei Pietro , Minniti Giuseppe , Peri Alessandro , Ruini Chiara , Settanni Fabio , Silvani Antonio , Veronese Nadia , Grimaldi Franco , Attanasio Roberto

Aim: This guideline (GL) is aimed at providing a reference for the management of prolactin (PRL)-secreting pituitary adenoma in non-pregnant adults.Methods: For each question, the panel identified potentially relevant outcomes, which were then rated for their impact on therapeutic choices.Results: The present GL provides recommendations about the roles of pharmacological and neurosurgical treatment for the management of prolactinom...